Our holiday shipping schedule
Make sure your orders arrive on time by checking our holiday shipping schedule.
Find suitable products, scientific resources or answers to your questions within our technical library FAQ.
Checkout using your account
This form is protected by reCAPTCHA - the Google Privacy Policy and Terms of Service apply.
Checkout as a new customer
Creating an account has many benefits:
Make sure your orders arrive on time by checking our holiday shipping schedule.
Discover our latest eBook, created with RegMedNet, featuring expert insights and clinical research on overcoming key challenges in adoptive cell therapy for solid tumors. Explore the future of personalized cancer treatment through peer-reviewed studies and practical applications.
PromoCell GmbH, a leading global manufacturer of primary human cells and specialized cell culture media for biomedical research, announces its entry into the Good Manufacturing Practice (GMP) field.
Allogeneic cell therapies offer off-the-shelf solutions that can benefit multiple patients from a single donor source. Read on to learn more.
Advances in immuno-oncology continue to transform cancer treatment, offering hope where traditional therapies have fallen short.
Our new BPE-free and xeno-free formulations allow researchers to obtain reliable data across a range of applications, from basic studies to translational research.
The integrity of the supply chain is a cornerstone of successful cell culture manufacturing. It directly influences product quality, regulatory compliance, and patient safety.
To help us turn this nomination into an award, you can cast your vote now until April 25, 2025.
Transforming the landscape of fibroblast research, our new Fibroblast Growth Medium D-ACF sets a new gold standard in cell culture.
This innovative medium revolutionizes the in vitro...Human Leukocyte Antigen (HLA) typing is critical for personalized medicine, immunotherapy, and understanding autoimmune diseases. Gain expert insights into the latest advances in HLA research from our...